Projects funded by the NCN
Evaluation of anti-neoplastic activity of LAB-derived postbiotics as a potential tool to support standard chemotherapy in the most common types of cancer that affect women
2022/47/O/NZ7/01089
Keywords:
Postbiotics LAB probiotics breast cancer gynecologic cancers
Descriptors:
- NZ7_014:
- NZ3_003:
- NZ5_007:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Łodzi, Wydział Nauk o Zdrowiu
woj. łódzkie
Principal investigator (from the host institution):
Number of co-investigators in the project: 2
Call: PRELUDIUM BIS 4 - announced on 2022-07-15
Amount awarded: 687 800 PLN
Project start date (Y-m-d): 2023-10-01
Project end date (Y-m-d): 2027-09-30
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
- Publication in academic press/journals (1)
- Lactic Acid Bacteria-Derived Postbiotics as Adjunctive Agents in Breast Cancer Treatment to Boost the Antineoplastic Effect of a Conventional Therapeutic Comprising Tamoxifen and a New Drug Candidate: An Aziridine–Hydrazide Hydrazone DerivativeAuthors:Joanna Wasiak, Pola Głowacka, Agnieszka Pudlarz, Adam M Pieczonka, Katarzyna Dzitko, Janusz Szemraj, Monika Witusik-PerkowskaAcademic press:Molecules (rok: 2024, tom: 29, strony: 2292), Wydawca: MDPIStatus:PublishedDOI:10.3390/molecules29102292 - link to the publication